Héctor A. Vaquera
@vaquerah-md.bsky.social
🇲🇽 Research fellow at Hematology Dept @uanl | Hematology. Lymphomas. Myeloma. HSCT.🩸🎗️
- OS with observation seem strange, what were control arm patients treated with upon progression?
A phase 3 trial new to this conversation is valuable but with even a not-so-universal definition of HRSMM (+ other things) results are difficult to interprete
A phase 3 trial new to this conversation is valuable but with even a not-so-universal definition of HRSMM (+ other things) results are difficult to interprete
December 7, 2024 at 6:47 PM
- OS with observation seem strange, what were control arm patients treated with upon progression?
A phase 3 trial new to this conversation is valuable but with even a not-so-universal definition of HRSMM (+ other things) results are difficult to interprete
A phase 3 trial new to this conversation is valuable but with even a not-so-universal definition of HRSMM (+ other things) results are difficult to interprete
November 25, 2024 at 2:32 PM